Jpmorgan Chase & CO Valens Company, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 13, 2023	BUY	$0.64 - $1.02 $29,658 - $47,268	46,342 Added 43.08%	153,910 $102,000
Q3 2022 Nov 14, 2022	SELL	$0.64 - $1.22 $189,504 - $361,242	-296,100 Reduced 73.35%	107,568 $72,000
Q2 2022 Aug 11, 2022	BUY	$0.61 - $1.69 $246,237 - $682,198	403,668 New	403,668 $262,000

Others Institutions Holding VLNS

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Valens Company, Inc.

Ticker VLNS
Exchange NASDAQ
Description
The Valens Company Inc. develops, manufactures, and sells cannabinoid-based products in Canada and internationally. It produces dried cannabis and hemp biomass products. The company also provides a range of products, including tinctures, two-piece caps, soft gels, oral sprays, and vape pens, as well as beverages, concentrates, topicals, edibles,...

More about VLNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.